Arovella Therapeutics Limited (ASX:ALA)
Australia · Delayed Price · Currency is AUD 0.0890
0.00 (0.00%)
Aug 25, 2025, 3:59 PM AEST
Arovella Therapeutics Market Cap
Arovella Therapeutics has a market cap or net worth of 105.87 million as of August 25, 2025. Its market cap has decreased by -38.97% in one year.
Market Cap
105.87M
Enterprise Value
84.99M
Revenue
3.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since January 24, 2002, Arovella Therapeutics's market cap has increased from 17.67M to 105.87M, an increase of 498.96%. That is a compound annual growth rate of 7.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2025 | 105.87M | -41.22% |
| Dec 31, 2024 | 180.10M | 72.28% |
| Dec 29, 2023 | 104.54M | 574.83% |
| Dec 30, 2022 | 15.49M | -17.41% |
| Dec 31, 2021 | 18.76M | 22.25% |
| Dec 31, 2020 | 15.34M | 85.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 104.88B |
| Pro Medicus | 32.01B |
| Cochlear | 19.74B |
| Sonic Healthcare | 12.16B |
| Ramsay Health Care | 8.78B |
| Telix Pharmaceuticals | 6.20B |
| Ansell | 4.53B |
| Mesoblast | 3.05B |